No Match Found
As one of world’s largest professional services firms, PwC offers you the benefits of experience gained from working with a wide range of clients, a global network of firms with industry dedicated professionals and an extraordinary depth and breadth of services.
Pharmaceutical and Life Sciences companies are facing unprecedented challenges globally and must have the scientific, commercial, and operational capabilities necessary to thrive in an increasingly complex health care environment and emerge stronger. We work with organisations across the industry value chain - from Biotech to Big Pharma and from CRO to Medical Device - to innovate, thrive and grow, from strategy through execution.
PwC's pharmaceuticals and life sciences practice helps pharmaceutical, biotech and medical device clients develop future-focused business strategies and to implement the time critical programmes and procedures essential to success within worldwide regulatory frameworks.
PwC’s global network of pharmaceutical, biotech and medtech experts works with you to define and deliver effective solutions to the complex challenges affecting your business in all areas from innovation to regulation and patient engagement.
We work closely with our clients to formulate a new strategy for success and achieve increased performance by improving the efficiency and effectiveness of the company’s R&D operations. We help our clients evaluate their R&D Strategy and Portfolio Management, improve management and control, and identify cost saving initiatives.
The pharmaceutical and life sciences industries are among the most heavily regulated in the world. The regulatory and tax environments are continuously changing in response to globalisation, emerging markets, increasing complexity of disease targets, introduction of new technologies and the rising sophistication and demands of both patients and regulators. Keeping pace with changing regulation requires good processes and procedures which ensure adherence and enable effective global, national and local management. We work with our clients to audit and develop management systems which enable greater transparency across the firm, inform the development of new approaches to a broad range of regulatory and tax compliance, and help improve performance. We also help in Manufacturing Quality remediation and transformation.
A combination of regulatory, market, scientific, and technological forces is likely to mean that pharmaceutical manufacturing will undergo rapid change in the next five to ten years. There is a need for companies to more consistently align investment in IT, quality and manufacturing with their vision of the manufacturing that will be needed in the future. In doing so, companies will be able to ensure that investments do not just deliver specific gains, but also help accelerate the company's progress toward longer term goals. We can help companies achieve the change required and their goals by utilising our firm's in-depth industry expertise.
Today companies are concerned about the cost and efficiency of their supply chain. Ensuring near term business continuity is critical; resilient supply chains will also effectively navigate around risk “icebergs”. We work with our clients to help them identify options at an early stage of the business and product planning process. We work with them to understand the potential risks, find solutions and identify the appropriate partners to help them reduce costs or gain entry into new markets.
In the current environment of poor product pipelines and broader customer bases, the traditional sales and marketing model of driving revenue with ever larger sales forces is no longer sustainable. Rather organisations will evolve to become more efficient and deliver differentiated effective messages tailored to the specific needs of diverse customer segments including patients, insurers, government and physicians, and the changes on product mix. PwC can work with you in targeting sales and marketing resources accordingly to the customer needs and the relevant regulations (compliance), avoiding components that are not helping to maximise the return on investment; improving the division of roles between the headquarters and local marketing companies with redefinition of planning and communication systems that work effectively between global, regional and marketing affiliates.
Pharmaceuticals and life Sciences companies invest heavily in their people. The challenge is to make sure that investment is effective, attracting and retaining people with great skills, and motivating them to do the right things in the right way. We work with our clients to deliver solutions on all issues relevant to their people development, reward and management of employees within pharmaceuticals organisations.
Together with our clients, we use a combination of industry and technology expertise to develop process improvements that assist you in getting value from technology investments, We bring knowledge in IT strategy, IT architecture and design, enterprise applications, Data and analytics, Cybersecurity, emerging technologies, RPA, sourcing, project management and IT operations management as well as experience of our professional advisors who have worked within R&D, Supply chain and manufacturing within the industry. At PwC, we help you enable trust in digital, data-driven world.
In collaboration with our clients, we use a combination of industry, data, analytical and technology expertise to develop process improvements that assist you in gaining value from technology investments. We bring knowledge in IT strategy, enterprise applications, and analytical technologies, as well as the experience of our advisors who have worked within R&D, Supply chain and manufacturing within the industry.
The Pharmaceutical and Life Sciences industries are among the most heavily regulated industries in the world. The regulatory environment is continuously changing in response to the effects of globalisation and harmonisation, emerging markets, increasing complexity of disease targets, introduction of new technologies and the rising sophistication and demands of both patients and regulators. Yet adherence to regulatory requirements is vital to both a company's and the industry's reputation. Keeping pace with changing regulation requires good processes and procedures which ensure adherence and enable effective global, national and local management. We work with our clients to audit and develop management systems which enable greater transparency across the firm, inform the development of new approaches to a broad range of regulatory compliance, risk management procedures and help improve performance.
We help create value beyond deals. PwC aims to address the emerging client requirement of having a single consulting organization partner across entire deal lifecycle, capturing maximum value from every point in the deal transaction and helping accelerate corporate strategy making GROWTH and VALUE the cornerstone of the Deals team construct.
The pharmaceuticals and life sciences industry is uniquely positioned to create value for society as its innovations lay the foundation for universal health and thus prosperity. However, it also raises expectations and sharpens the focus towards the subject of sustainability in the industry.
From assessing the various strategic implications of climate change to assessing social impact through to implementing the reporting requirements: The ESG experts at PwC and Strategy& will advise you on every facet of sustainable corporate governance. We will work with you to shape your company's strategy to transformation journey - for the success of your long-term sustainable business. Companies that take measures now can significantly reduce future costs and risks and simultaneously increase their value. We support our clients in mastering this challenge and create sustainable value for the company, society, and the environment.
We believe that transformation is a major shift in an organisation's capabilities and identity so that it can deliver valuable results, relevant to its purpose, that it couldn't master before. You might never use the word “transformation” because mastering change becomes second nature to your people, not something imposed on them. Successful transformations should do more than achieve the end state – they must build both a transformation capability and organisational agility.
Our response to the digital transformation consulting needs of our clients is centered around six solutions which are the bedrock of delivering a successful transformational journey.
PwC Global Health Industries Advisory Leader, India Health Industries Leader, PwC India